Second salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer.

Maenhout, Metha; van Vulpen, Marco; Moerland, Marinus; Peters, Max; Meijer, Richard; van den Bosch, Maurice; Nguyen, Paul; Frank, Steven; van der Voort van Zyp, Jochem

Maenhout, Metha; van Vulpen, Marco; Moerland, Marinus; Peters, Max; Meijer, Richard; van den Bosch, Maurice; Nguyen, Paul; Frank, Steven; van der Voort van Zyp, Jochem.

Afiliación

Maenhout M; Department of Radiotherapy, University Medical Center Utrecht, Netherlands.
van Vulpen M; Department of Radiotherapy, University Medical Center Utrecht, Netherlands.
Moerland M; Department of Radiotherapy, University Medical Center Utrecht, Netherlands.
Peters M; Department of Radiotherapy, University Medical Center Utrecht, Netherlands.
Meijer R; Department of Urology, University Medical Center Utrecht, Netherlands.
van den Bosch M; Department of Radiology, University Medical Center Utrecht, Netherlands.
Nguyen P; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.
Frank S; Department of Radiotherapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
van der Voort van Zyp J; Department of Radiotherapy, University Medical Center Utrecht, Netherlands.

J Contemp Brachytherapy ; 9(2): 161-166, 2017 Apr.

Article en En | MEDLINE | ID: mdl-28533806

Palabras clave

HDR brachytherapy; MRI guided; recurrent prostate cancer; second salvage treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Contemp Brachytherapy Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google